Effects of Traditional Chinese Medicine on AECOPD Patients
Status:
Unknown status
Trial end date:
2019-12-31
Target enrollment:
Participant gender:
Summary
This is a multi-center, randomized, double-blind, controlled trial to compare the efficacy of
two therapies for patients with AECOPD. 378 subjects will be randomly assigned to one
therapies (conventional drug, and the combination of conventional drug and TCM) for 14 days
treatment. After the treatment period, subjects in two arms will be followed up for 4 weeks.
The primary outcomes will include COPD Assessment Test (CAT), and secondary outcomes include
treatment failure rate, treatment success rate, hospitalization time, hospital admission
rate, endotracheal intubation rate, mortality and quality of life (COPD-PRO, SF-36).